Research Roundup

green light new law approval
Debbie Rigby takes a look at the latest in research news Management of type 2 diabetes in patients with frailty Newer antihyperglycemic agents such as glucagonlike peptide-1 receptor agonists (GLP1-RAs), dipeptidyl peptidase 4 inhibitors (DPP4Is), and sodium-glucose cotransporter-2 inhibitors (SGLT2Is) are therapeutic options for older patients due to these agents’ low hypoglycaemic risk and benefits

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Aurora Cannabis acquires MedReleaf
Next ‘Circumvention of the rules’ leads to pharmacist’s tribunal hearing